Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and
tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in
the treatment of ocular inflammation associated with blepharokeratoconjunctivitis (BKC).